Re­call re­port: Teva's chemother­a­py drug re­called af­ter in­ves­ti­ga­tors find par­tic­u­lates in­side vials

A chemother­a­py drug from Te­va Phar­ma­ceu­ti­cals has been vol­un­tar­i­ly re­called af­ter a com­plaint from a phar­ma­cy that par­tic­u­late was found in­side a glass vial.

The com­pa­ny iden­ti­fied two par­tic­u­lates in a vial of topote­can in­jec­tion: grey sil­i­con par­ti­cle and a translu­cent, col­or­less cot­ton fiber, the FDA said. One lot, with an ex­pi­ra­tion date of April 2022, has been re­called. The lot has a dosage of 4 mg/4 mL (1 mg/mL).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER